Hyperbilirubinemia Does Not Influence Persistence with Atazanavir Treatment
PHILADELPHIA, PA—Hyperbilirubinemia does not appear to influence persistence with atazanavir (ATV) in a “real-world setting,” results of a retrospective analysis reported at IDWeek 2014 have found. To determine whether patients with HIV have poor ...
Monthly Prescribing Reference - Sat, 11 Oct 2014 08:56



New Approaches Emerge for Treating ALL, Yet Challenges Remain
Toxicities in the AYA cohort were similar to those experienced by pediatric patients receiving the regimen in the COG 0232 study, including ALT elevation in approximately 50% of patients in both in the AYA and pediatric populations and ...
OncLive - Mon, 23 Feb 2015 08:41

Most Popular Stories
If serious liver injury with clinical symptoms and/or hyperbilirubinemia or jaundice occurs during treatment, therapy should be interrupted promptly and not restarted unless an alternate etiology is found. Increases in HbA1c and fasting serum glucose ...
Rock Hill Herald (press release) - Wed, 25 Feb 2015 04:56

SAPPHIRE-I, II: Treatment sustained despite hyperbilirubinemia in some HCV ...
Researchers, including Gregory T. Everson, MD, of the University of Colorado in Denver, analyzed the frequency of hyperbilirubinemia and clinical jaundice in patients with HCV genotype 1 (n=770) enrolled in the SAPPHIRE-I and II phase 3 trials and ...
Healio - Wed, 10 Sep 2014 12:26

Intellectual disability
Among the risk factors related to intellectual disability, according to MedlinePlus, are chromosomal abnormalities such as Down Syndrome; environmental factors; metabolic problems such as hyperbilirubinemia (very high bilirubin levels in babies); ...
BusinessWorld Online Edition - Thu, 19 Feb 2015 07:22

Monovalent Ebola vaccine appeared safe in early trial
Prolonged activated partial-thromboplastin times were observed in four patients, transient hyperbilirubinemia was observed in eight patients, and two participants developed a fever that subsided within 24 hours. Researchers also observed an increase in ...
Healio - Fri, 30 Jan 2015 03:46



Alectinib Promising In Anaplastic Lymphoma Kinase-Positive Non-Small Cell ...
The inhibitor was well tolerated by the individuals without significant adverse events, although the dose had to be reduced for one of the patients as she developed grade 2 hyperbilirubinemia. The study shows that alectinib has a significant antitumor ...
Lung Cancer News Today - Fri, 06 Feb 2015 04:03

AAP Issues Guidelines on Phototherapy for Neonates
September 26, 2011 — The American Academy of Pediatrics has released recommendations to standardize phototherapy in newborns with hyperbilirubinemia with respect to variables such as light source intensity, spectral output, and irradiance meters, and ...
Medscape - Mon, 26 Sep 2011 08:06


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014